Circularly Permuted TRAIL (CPT) combined with Thalidomide for the Treatment of Relapsed or Refractory Multiple Myeloma: An Open-Label, Multicenter Phase II Clinical Trial.
单位：[1]Capital Med Univ, Chaoyang Hosp, Beijing, Peoples R China北京朝阳医院[2]Second Mil Med Univ, Chang Zheng Hosp, Dept Hematol, Shanghai, Peoples R China[3]CAMS, Inst Hematol, Dept Lymphoma Ctr, Tianjin, Peoples R China[4]CAMS, Blood Dis Hosp, Tianjin, Peoples R China[5]PUMC, Tianjin, Peoples R China[6]CAMS, State Key Lab Expt Hematol, Inst Hematol, Tianjin, Peoples R China[7]Peking Univ, Hosp 3, Beijing, Peoples R China[8]Capital Med Univ, Beijing Friendship Hosp, Beijing, Peoples R China首都医科大学附属北京友谊医院[9]Beijing Sunbio Biotech Co Ltd, Beijing, Peoples R China[10]Heibei Med Univ, Hosp 2, Shijiazhuang, Hebei, Peoples R China
第一作者单位：[1]Capital Med Univ, Chaoyang Hosp, Beijing, Peoples R China
推荐引用方式(GB/T 7714)：
Chen Wenming,Hou Jian,Zhao Yaozhong,et al.Circularly Permuted TRAIL (CPT) combined with Thalidomide for the Treatment of Relapsed or Refractory Multiple Myeloma: An Open-Label, Multicenter Phase II Clinical Trial.[J].BLOOD.2012,120(21):doi:10.1182/blood.V120.21.2958.2958.
APA：
Chen, Wenming,Hou, Jian,Zhao, Yaozhong,Qiu, Lugui,Ke, Xiaoyan...&Yang, Shifang.(2012).Circularly Permuted TRAIL (CPT) combined with Thalidomide for the Treatment of Relapsed or Refractory Multiple Myeloma: An Open-Label, Multicenter Phase II Clinical Trial..BLOOD,120,(21)
MLA：
Chen, Wenming,et al."Circularly Permuted TRAIL (CPT) combined with Thalidomide for the Treatment of Relapsed or Refractory Multiple Myeloma: An Open-Label, Multicenter Phase II Clinical Trial.".BLOOD 120..21(2012)
医学